Improvement of glucose homeostasis during leptin treatment does not alter the intestinal microbiome in male diabetic UC Davis type-2 diabetes mellitus rats
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.05.2026 · 330 (5) · G549-G564
DOI: 10.1152/ajpgi.00412.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.05.2026. Verfasst von Manuel Martínez-Ruiz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Arkansas Children's Nutrition Center, Little Rock, Arkansas, United States. Hauptthemen laut MEDLINE: Leptin, Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Blood Glucose. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, USDA | Agricultural Research Service (ARS), NIA NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Our data indicate that chronic administration of recombinant leptin in diabetic UCD-T2DM rats does not change the gut microbiome, despite improvements in food intake, glucose homeostasis, and insulin sensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Arkansas Children's Nutrition Center, Little Rock, Arkansas, United States.
- Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States.
- Department of Molecular Biosciences, School of Veterinary Medicine, UC Davis, California, United States.
- Department of Nutrition, UC Davis, California, United States.
- Arkansas Children's Research Institute, Little Rock, Arkansas, United States.
- Department of Biomedical Science and Pathobiology, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, United States.
ORCID-Profile: Manuel Martínez-Ruiz, James L Graham, Renee Fox, Renny Lan, Lindsay Pack, Laxmi Yeruva, Brian D Piccolo
Förderung
- NCATS NIH HHS
- USDA | Agricultural Research Service (ARS)
- NIA NIH HHS
- HHS | NIH | National Center for Advancing Translational Sciences (NCATS)
- NIDDK NIH HHS
- HHS | NIH | National Institute on Aging (NIA)
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
Zitieren
APA
Martínez-Ruiz, M., Tabor-Simecka, L., Graham, J. L., Randolph, C., Fox, R., Lan, R., Pack, L., LeRoith, T., Stanhope, K. L., Yeruva, L., Havel, P. J., & Piccolo, B. D. (2026). Improvement of glucose homeostasis during leptin treatment does not alter the intestinal microbiome in male diabetic UC Davis type-2 diabetes mellitus rats. American Journal of Physiology-Gastrointestinal and Liver Physiology, 330(5), G549-G564. https://doi.org/10.1152/ajpgi.00412.2025
Vancouver
Martínez-Ruiz M, Tabor-Simecka L, Graham JL, Randolph C, Fox R, Lan R, et al. Improvement of glucose homeostasis during leptin treatment does not alter the intestinal microbiome in male diabetic UC Davis type-2 diabetes mellitus rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2026;330(5):G549-G564. doi:10.1152/ajpgi.00412.2025
BibTeX
@article{MartnezRuiz2026,
author = {Martínez-Ruiz, Manuel and Tabor-Simecka, Leslie and Graham, James L and Randolph, Christopher and Fox, Renee and Lan, Renny and Pack, Lindsay and LeRoith, Tanya and Stanhope, Kimber L and Yeruva, Laxmi and Havel, Peter J and Piccolo, Brian D},
title = {Improvement of glucose homeostasis during leptin treatment does not alter the intestinal microbiome in male diabetic UC Davis type-2 diabetes mellitus rats},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2026},
volume = {330},
number = {5},
pages = {G549--G564},
doi = {10.1152/ajpgi.00412.2025}
}
EUVIMED